# Low Dose Versus Aggressive Inhibition of the Renin-Angiotensin-Aldosterone (RAS) to Treat Microalbuminuria

> **NCT00907374** · NA · COMPLETED · sponsor: **Charles Drew University of Medicine and Science** · enrollment: 46 (actual)

## Conditions studied

- Microalbuminuria

## Interventions

- **DRUG:** benazepril
- **DRUG:** benazepril

## Key facts

- **NCT ID:** NCT00907374
- **Lead sponsor:** Charles Drew University of Medicine and Science
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2012-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00907374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00907374, "Low Dose Versus Aggressive Inhibition of the Renin-Angiotensin-Aldosterone (RAS) to Treat Microalbuminuria". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00907374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*